Table 2.
Predictive effect of the three screeners as sum score values on service use by dimensions of willingness and types of services at t1 and t2
| t1 (3-month follow-up) | t2 (6-month follow-up) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| N | Β (SE) | pa | OR | N | Β (SE) | pa | OR | ||
| Need | |||||||||
| PHQ-9 | Social service | 313 | 0.10 (0.03) | <.001 | 1.11 | 212 | 0.14 (0.03) | <.001 | 1.15 |
| Psycho-onco | 313 | 0.09 (0.03) | <.001 | 1.10 | 217 | 0.13 (0.03) | <.001 | 1.14 | |
| Survivorship | 313 | 0.09 (0.03) | .003 | 1.09 | 208 | 0.04 (0.04) | .360 | 1.04 | |
| GAD-7 | Social service | 314 | 0.11 (0.03) | <.001 | 1.12 | 214 | 0.18 (0.04) | <.001 | 1.19 |
| Psycho-onco | 314 | 0.13 (0.03) | <.001 | 1.13 | 219 | 0.18 (0.04) | <.001 | 1.20 | |
| Survivorship | 314 | 0.08 (0.04) | .028 | 1.08 | 209 | 0.11 (0.05) | .017 | 1.12 | |
| DT | Social service | 308 | 0.16 (0.06) | .006 | 1.17 | 206 | 0.18 (0.07) | .017 | 1.19 |
| Psycho-onco | 308 | 0.19 (0.06) | .002 | 1.21 | 211 | 0.20 (0.07) | .006 | 1.22 | |
| Survivorship | 308 | 0.17 (0.07) | .012 | 1.19 | 202 | 0.05 (0.09) | .559 | 1.05 | |
| Intention | |||||||||
| PHQ-9 | Social service | 291 | 0.07 (0.03) | .005 | 1.08 | 199 | 0.10 (0.04) | .003 | 1.11 |
| Psycho-onco | 291 | 0.09 (0.03) | <.001 | 1.10 | 202 | 0.14 (0.04) | <.001 | 1.15 | |
| Survivorship | 289 | 0.08 (0.03) | .008 | 1.08 | 200 | 0.08 (0.04) | .024 | 1.08 | |
| GAD-7 | Social service | 292 | 0.09 (0.03) | .004 | 1.09 | 201 | 0.12 (0.04) | .003 | 1.13 |
| Psycho-onco | 292 | 0.09 (0.03) | .004 | 1.10 | 204 | 0.14 (0.04) | <.001 | 1.15 | |
| Survivorship | 290 | 0.07 (0.03) | .032 | 1.07 | 201 | 0.10 (0.04) | .018 | 1.10 | |
| DT | Social service | 286 | 0.02 (0.01) | .143 | 1.02 | 193 | 0.05 (0.08) | .501 | 1.05 |
| Psycho-onco | 286 | 0.07 (0.06) | .240 | 1.08 | 196 | 0.19 (0.08) | .014 | 1.20 | |
| Survivorship | 284 | 0.13 (0.07) | .050 | 1.14 | 194 | 0.09 (0.08) | .276 | 1.09 | |
| Utilization | |||||||||
| PHQ-9 | Social service | 322 | 0.05 (0.03) | .084 | 1.05 | 237 | 0.02 (0.03) | .537 | 1.02 |
| Psycho-onco | 324 | 0.07 (0.03) | .006 | 1.08 | 236 | 0.06 (0.03) | .050 | 1.07 | |
| Survivorship | 314 | −0.12 (0.10) | .216 | 0.88 | 235 | 0.01 (0.12) | .948 | 1.01 | |
| GAD-7 | Social service | 323 | 0.02 (0.03) | .503 | 1.02 | 239 | 0.06 (0.04) | .116 | 1.06 |
| Psycho-onco | 325 | 0.08 (0.03) | .010 | 1.09 | 238 | 0.09 (0.04) | .015 | 1.10 | |
| Survivorship | 315 | −0.12 (0.12) | .342 | 0.89 | 237 | 0.05 (0.13) | .690 | 1.05 | |
| DT | Social service | 317 | 0.12 (0.06) | .042 | 1.12 | 231 | 0.13 (0.07) | .056 | 1.14 |
| Psycho-onco | 319 | 0.17 (0.06) | .005 | 1.19 | 230 | 0.24 (0.08) | .003 | 1.27 | |
| Survivorship | 309 | −0.12 (0.17) | .473 | 0.88 | 229 | −0.10 (0.27) | .714 | 0.91 | |
All regressions are controlled for intervention, age, and gender; B, unstandardized regression coefficient; SE, standard error; p, unadjusted p-value of the regression model; OR, odds-ratio; aBonferroni-Holm adjusted alpha-level αadjusted=0.05/(18−k+1) with k=rank number of p-value, significant p-values after adjustment are marked in bold